FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Didanosine Delayed-Release Capsules USP
Status: Discontinuation
»Therapeutic Categories: Antiviral

Expand all

Mylan Pharmaceuticals Inc. (New 03/11/2016)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Didanosine Delayed-release Capsules USP, 125 mg, 30s (NDC 0378-8886-93) N/A A business decision to discontinue manufacture of the drug. The product discontinuation is not related to product safety or efficacy..
Didanosine Delayed-release Capsules USP, 200 mg, 30s (NDC 0378-8887-93) N/A A business decision to discontinue manufacture of the drug. The product discontinuation is not related to product safety or efficacy..
Didanosine Delayed-release Capsules USP, 250 mg, 30s (NDC 0378-8888-93) N/A A business decision to discontinue manufacture of the drug. The product discontinuation is not related to product safety or efficacy..
Didanosine Delayed-release Capsules USP, 400 mg, 30s (NDC 0378-8889-93) N/A A business decision to discontinue manufacture of the drug. The product discontinuation is not related to product safety or efficacy..

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English